DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
LERIGLITAZONE
2
Small molecule
Investigational
Unknown
Unknown
Adrenoleukodystrophy; Friedreich Ataxia
Peroxisome proliferator-activated receptor gamma agonist
LERIGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
K824X25AYA
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O4S
Molecular Weight:
372.45
AlogP:
2.65
PSA:
88.52
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PHOSPHOCREATINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHOSPHOCREATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEFERITAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DEFERITAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
4D8DC53Y1L
Molecule Type:
Small molecule
Molecular Formula:
C18H25NO7S
Molecular Weight:
399.47
AlogP:
1.79
PSA:
106.81
HBD:
2.0
HBA:
#RotB:
12.0
Source:
GS-9131
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GS-9131
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DNK333
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic; Irritable Bowel Syndrome
Neurokinin 1 receptor antagonist
DNK333
×
Maximum Phase:
2
First Approval:
None
UNII:
G9BL4978MZ
Molecule Type:
Small molecule
Molecular Formula:
C27H25Cl2F6N3O3
Molecular Weight:
624.41
AlogP:
6.06
PSA:
78.51
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NAVARIXIN
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Psoriasis; Pulmonary Disease, Chronic Obstructive
Interleukin-8 receptor A antagonist
NAVARIXIN
×
Maximum Phase:
2
First Approval:
None
UNII:
7V3BY6G538
Molecule Type:
Small molecule
Molecular Formula:
C21H23N3O5
Molecular Weight:
397.43
AlogP:
2.9
PSA:
111.88
HBD:
3.0
HBA:
#RotB:
7.0
Source:
MT-8554
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MT-8554
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PYRUVATE
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Glaucoma, Open-Angle
Unknown
PYRUVATE
×
Maximum Phase:
2
First Approval:
None
UNII:
8558G7RUTR
Molecule Type:
Small molecule
Molecular Formula:
C3H4O3
Molecular Weight:
88.06
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
POZANICLINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Tobacco Use Disorder
Neuronal acetylcholine receptor; alpha6/beta2 partial agonist
POZANICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
CL2002R563
Molecule Type:
Small molecule
Molecular Formula:
C11H16N2O
Molecular Weight:
192.26
AlogP:
1.52
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PER977
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PER977
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAR-125844
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
SAR-125844
×
Maximum Phase:
2
First Approval:
None
UNII:
XH93U6NIJE
Molecule Type:
Small molecule
Molecular Formula:
C25H23FN8O2S2
Molecular Weight:
550.65
AlogP:
4.15
PSA:
109.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GSK-2636771
2
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms; Stomach Neoplasms; Multiple Myeloma
PI3-kinase p110-beta subunit inhibitor
GSK-2636771
×
Maximum Phase:
2
First Approval:
None
UNII:
DW94IAT0LS
Molecule Type:
Small molecule
Molecular Formula:
C22H22F3N3O3
Molecular Weight:
433.43
AlogP:
4.26
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
(+/-)NICOTINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
(+/-)NICOTINE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2
Molecular Weight:
162.24
AlogP:
1.85
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
1.0
Source:
SUVECALTAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Essential Tremor; Schizophrenia
Voltage-gated T-type calcium channel modulator
SUVECALTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
MIA4WMP8QN
Molecule Type:
Small molecule
Molecular Formula:
C20H23F3N2O2
Molecular Weight:
380.41
AlogP:
4.57
PSA:
51.22
HBD:
1.0
HBA:
#RotB:
7.0
Source:
RIVIPANSEL SODIUM
2
Small molecule
Investigational
Unknown
Unknown
Anemia, Sickle Cell
Unknown
RIVIPANSEL SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
11AEN6VWDN
Molecule Type:
Small molecule
Molecular Formula:
C58H70N6Na4O31S3
Molecular Weight:
1535.37
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EVATANEPAG
2
Small molecule
Investigational
Unknown
Unknown
Tibial Fractures
Prostanoid EP2 receptor agonist
EVATANEPAG
×
Maximum Phase:
2
First Approval:
None
UNII:
L266R6E31E
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O5S
Molecular Weight:
468.58
AlogP:
4.23
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
VALATEGRAST
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Unknown
VALATEGRAST
×
Maximum Phase:
2
First Approval:
None
UNII:
06DM4KX7JG
Molecule Type:
Small molecule
Molecular Formula:
C30H32Cl3N3O4
Molecular Weight:
604.96
AlogP:
6.43
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
12.0
Source:
FENEBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Autoimmune Diseases; Arthritis, Rheumatoid; Lupus Erythematosus, Systemic; Urticaria; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
Tyrosine-protein kinase BTK inhibitor
FENEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
E9L2885WUL
Molecule Type:
Small molecule
Molecular Formula:
C37H44N8O4
Molecular Weight:
664.81
AlogP:
3.57
PSA:
120.99
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BCX-1777
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BCX-1777
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LETEPRINIM POTASSIUM
2
Small molecule
Investigational
Unknown
Unknown
Memory Disorders; Peripheral Nervous System Diseases
Unknown
LETEPRINIM POTASSIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Q06WU8JY4F
Molecule Type:
Small molecule
Molecular Formula:
C15H12KN5O4
Molecular Weight:
365.39
AlogP:
0.85
PSA:
129.97
HBD:
3.0
HBA:
#RotB:
5.0
Source:
DS107G
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DS107G
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK0686
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Osteoarthritis; Pain
Bradykinin B1 receptor antagonist
MK0686
×
Maximum Phase:
2
First Approval:
None
UNII:
M310323W0U
Molecule Type:
Small molecule
Molecular Formula:
C22H19ClF4N2O4
Molecular Weight:
486.85
AlogP:
4.32
PSA:
84.5
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PF-07321332
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-07321332
×
Maximum Phase:
2
First Approval:
None
UNII:
7R9A5P7H32
Molecule Type:
Small molecule
Molecular Formula:
C23H32F3N5O4
Molecular Weight:
499.53
AlogP:
1.1
PSA:
131.4
HBD:
3.0
HBA:
#RotB:
6.0
Source:
L-756423
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-756423
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ERTEBEREL
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Hyperplasia; Schizophrenia
Estrogen receptor beta agonist
ERTEBEREL
×
Maximum Phase:
2
First Approval:
None
UNII:
2ZUL6758TZ
Molecule Type:
Small molecule
Molecular Formula:
C18H18O3
Molecular Weight:
282.34
AlogP:
4.12
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
1.0
Source:
ORNITHINE PHENYLACETATE
2
Small molecule
Investigational
Unknown
Unknown
Liver Cirrhosis; Liver Failure, Acute
Unknown
ORNITHINE PHENYLACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
9D6YZ105SN
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O4
Molecular Weight:
268.31
AlogP:
-0.86
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CP-724714
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasm Metastasis
Receptor protein-tyrosine kinase erbB-2 inhibitor
CP-724714
×
Maximum Phase:
2
First Approval:
None
UNII:
I05QZ0S4V3
Molecule Type:
Small molecule
Molecular Formula:
C27H27N5O3
Molecular Weight:
469.55
AlogP:
4.95
PSA:
98.26
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ALVELESTAT
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Severe Acute Respiratory Syndrome; Bronchiectasis; Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive
Leukocyte elastase inhibitor
ALVELESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
6Y5629322X
Molecule Type:
Small molecule
Molecular Formula:
C25H22F3N5O4S
Molecular Weight:
545.54
AlogP:
3.29
PSA:
115.95
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ARBACLOFEN PLACARBIL
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Back Pain; Gastroesophageal Reflux; Muscle Spasticity; Multiple Sclerosis
GABA-B receptor agonist
ARBACLOFEN PLACARBIL
×
Maximum Phase:
2
First Approval:
None
UNII:
W89H91R7VX
Molecule Type:
Small molecule
Molecular Formula:
C19H26ClNO6
Molecular Weight:
399.87
AlogP:
3.81
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
9.0
Source:
KRN5500
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Neuralgia
Unknown
KRN5500
×
Maximum Phase:
2
First Approval:
None
UNII:
8VH13L5K20
Molecule Type:
Small molecule
Molecular Formula:
C28H43N7O7
Molecular Weight:
589.69
AlogP:
0.42
PSA:
214.84
HBD:
8.0
HBA:
#RotB:
17.0
Source:
LENIOLISIB PHOSPHATE
2
Small molecule
Investigational
Unknown
Unknown
Common Variable Immunodeficiency; Sjogren's Syndrome; Primary Immunodeficiency Diseases
PI3-kinase p110-delta subunit inhibitor
LENIOLISIB PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
3700M1H39Q
Molecule Type:
Small molecule
Molecular Formula:
C21H28F3N6O6P
Molecular Weight:
548.46
AlogP:
2.88
PSA:
83.48
HBD:
1.0
HBA:
#RotB:
5.0
Source:
APRICOXIB
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms
Cyclooxygenase-2 inhibitor
APRICOXIB
×
Maximum Phase:
2
First Approval:
None
UNII:
5X5HB3VZ3Z
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3S
Molecular Weight:
356.45
AlogP:
3.5
PSA:
74.32
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DAR-0100A
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DAR-0100A
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-SULFORAPHANE
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
L-SULFORAPHANE
×
Maximum Phase:
2
First Approval:
None
UNII:
7J94TPZ10L
Molecule Type:
Small molecule
Molecular Formula:
C6H11NOS2
Molecular Weight:
177.29
AlogP:
1.25
PSA:
29.43
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ABEDITEROL
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
ABEDITEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
QXA167CM6F
Molecule Type:
Small molecule
Molecular Formula:
C25H30F2N2O4
Molecular Weight:
460.52
AlogP:
4.23
PSA:
94.58
HBD:
4.0
HBA:
#RotB:
13.0
Source:
1
2
…
87
88
89
90
91
92
93
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA